Coats’ Disease: Very Long-Term Outcome After Early Stage Conventional Treatment
Salvatore Perrone*, Alberto Rossetti, Patrick Sportiello, Pierfrancesco Mirabelli, Pierangela Cimatti, Daniele Doro
Identifiers and Pagination:Year: 2016
First Page: 22
Last Page: 26
Publisher Id: TOOPHTJ-10-22
Article History:Received Date: 20/10/2015
Revision Received Date: 30/11/2015
Acceptance Date: 30/11/2015
Electronic publication date: 29/2/2016
Collection year: 2016
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
To report on the outcome of conventional therapy in patients with Coats’ disease.
Retrospective analysis of the charts of thirteen patients with Coats’ disease.
Mean age of 9 male (70%) and 4 female (30%) patients was 17.7 (range, 5-33) years; one female had bilateral disease. Eleven eyes with retinal telangiectasia and exudation were treated with argon laser photocoagulation alone or photocoagulation associated with cryotherapy; the mean follow up was 32.5 (range,17-41) years. In four eyes without foveal involvement (stage 2a) the mean presenting visual acuity (VA) remained at 0.8 or improved, whereas poor VA in seven stage 2b eyes deteriorated minimally over time. In one and two of the three eyes with total retinal detachment, phthisis or neovascular glaucoma ensued.
About three decades after conventional treatment of Coats’ disease stage 2a, treated eyes maintained good VA, and stage 2b eyes did not progress to advanced stages.